Should new health technology be available only for patients able and willing to pay?

References

• Damiaan AZ. Oostende (Belgium): algemeen Ziekenhuis Damiaan; c2007–2017. Overzichtslijst aangeboden goederen en diensten. Niet vergoedbare implantaten [List of goods and services not covered by mandatory basic health insurance]; [Internet]. [ updated 2014 Aug 6; cited 2017 Apr 11]; [10 pages]. Dutch. Available from: http://www.azdamiaan.be/UserFiles/File/Overzichtslijst%20diverse%20goederen%20en%20diensten%20&%20niet-vergoedbare%20implantaten%20-%20SAP%209644(1).pdf
   Google Scholar
• SEZZ. Zottegem (Belgium): algemeen Ziekenhuis Sint-Elisabeth; c2017. Analyses buiten RIZIV-nomenclatuur [Clinical biology analyses not covered by mandatory basic health insurance]; [Internet]. [ updated 2015 Jan; [ cited 2017 Apr 11]; [4 pages]. Dutch. Available from: http://www.sezz.be/diensten/klinische-biologie/analyses-buiten-riziv-nomenclatuur.aspx
   Google Scholar
• Source: DKV Belgium (voluntary additional health insurance); anonymized billing information. Brussels: DKV Belgium; 2015.
   Google Scholar
• Source: zimmer Biomet Belgium (medical device company); Trabecular Metal Acetabular Revision System price list. Brussels: Zimmer Biomet Belgium; 2011.
   Google Scholar
• Bedaf M Waarom krijg ik geen MammaPrint? [Why do I not get a MammaPrint?]. B, het blad van borstkankervereniging Nederland. (1):20–212011. Dutch. Available from: http://bvn.turnpages.nl/blad/2011-1/index.00021.html
   Google Scholar
• EMA. London: european Medicines Agency; [Internet]. c1995–2017 [ cited 2017 Apr 11]. Available from: http://www.ema.europa.eu/ema/
   Google Scholar
• Medicijnkosten.nl The Netherlands: zorginstituut Nederland; [Internet]. [ updated 2017 March 8; cited 2017 Apr 11]. Dutch. Available from: https://www.medicijnkosten.nl/
   Google Scholar
• BCFI. Belgium: belgisch Centrum for Farmacotherapeutische Informatie; c2017 [Internet] [ cited 2017 Apr 11]. Dutch. Available from: http://www.bcfi.be/nl/start
   Google Scholar
• FDA. Silver Spring (MD): food and Drug Administration; [Internet]. [ updated 2017 April 11. Premarket approval Mobi-C cervical disc prosthesis; updated 2017 April 10 [cited 2017 April 11]; [about 2 screens]. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm?id=P110009
   Google Scholar
• NICE. London: national Institute for Health and Care Excellence; c2017. Prosthetic intervertebral disc replacement in the cervical spine [Internet]; [ updated 2010 May; cited 2017 Apr 11]; [about 2 screens]. Available from: https://www.nice.org.uk/guidance/IPG341/chapter/1-guidance
   Google Scholar
• Anthem. Indianopolis (IN): anthem Blue Cross Blue Shield; c2005–2017. Cervical total disc arthroplasty [Internet]; [ updated 2016 Nov 17; cited 2017 Apr 11]; [about 22 screens]. Available from: https://www.anthem.com/medicalpolicies/policies/mp_pw_a053354.htm
   Google Scholar
• Nederlands Zorginstituut [Dutch Health Care Institute]: cases 2011127677; 2012 February; and 2012035554; April2012. Dutch.
   Google Scholar
• Nederlands Zorginstituut [Dutch Health Care Institute]: cases 2010046133 and 2010132282 ; 2010 Oct. Dutch.
   Google Scholar
• Rijksoverheid. The Netherlands: rijksoverheid. Schippers geeft groen licht voor NIPT [Minister Schippers gives the green light for NIPT] [Internet]; [ updated 2013 Dec 17; cited 2017 Apr 11] [about 3 screens]. Dutch. Available from: https://www.rijksoverheid.nl/actueel/nieuws/2013/12/17/schippers-geeft-groen-licht-voor-nipt
   Google Scholar
• Rijksoverheid. The Netherlands: rijksoverheid. €26 miljoen voor NIPT als eerste test [€26 million for NIPT as a first test] [Internet]; [ updated 2016 Sep 20; cited 2017 Apr 11]. about 3 screens]. Dutch. Available from: https://www.rijksoverheid.nl/actueel/nieuws/2016/09/20/26-miljoen-voor-nipt-als-eerste-test
   Google Scholar
• ZiN. The Netherlands: zorginstituut Nederland [Dutch Health Care Institute]. Pakketadvies nivolumab [Advice on nivolumab]; [Internet] [ updated 2015 Dec 8; cited 2017 Apr 11]. Dutch. Available from: https://www.zorginstituutnederland.nl/publicaties/adviezen/2015/12/08/pakketadvies-nivolumab-opdivo
   Google Scholar
• Rijksoverheid. The Netherlands: rijksoverheid. Kamerbrief over beëindiging sluis nivolumab per 1 maart 2016 [Letter of Minister Schippers to Parliament on the coverage by mandatory basic health insurance of nivolumab as from 2016 March 1] [Internet]; [ updated 2016 Jan 18; cited 2017 Apr 11] [2 pages]. Dutch. Available from: https://www.rijksoverheid.nl/ministeries/ministerie-van-volksgezondheid-welzijn-en-sport/documenten/kamerstukken/2016/01/28/kamerbrief-over-beeindiging-sluis-nivolumab-per-1-maart-2016
   Google Scholar
• RIZIV. Belgium: rijksinstituut voor ziekte- en invaliditeitsverzekering. Het Bijzonder solidariteitsfonds: uitzonderlijke vergoeding van medische verstrekkingen [The Special solidarity fund: exceptional reimbursement of medical services] [Internet]; [ updated 2016 Mar 14; cited 2017 Apr 11]; [about 7 screens]. Dutch. Available from: http://www.inami.fgov.be/nl/themas/kost-terugbetaling/door-ziekenfonds/bijzonder-solidariteitsfonds/Paginas/default.aspx#.WOzu8GdMRZQ
   Google Scholar
• Assuralia. Belgium: assuralia. Private ziekteverzekeraars – aantal verzekerde personen [Private health insurance – number of insured] [Internet]; [ updated 2016 Nov 18; cited 2017 Apr 11]; [1 screen]. Dutch. Available from: http://assuralia.be/images/docs/stats/NL/02_kerncijfers-per-tak/02_11_aantal-verzekerden-ziekte.htm
   Google Scholar
• CDZ. Belgium: controledienst voor de Ziekenfondsen. Jaarverslag 2015 [Report 2015 mutualities] [Internet]; [ updated 2015 Dec 31; cited 2017 Apr 11]; [136 pages]. Dutch. Available from: http://www.ocm-cdz.be/hoofdframe-n.htm
   Google Scholar
• Article 8, §2 Wet van 22 augustus 2002 betreffende de rechten van de patiënt [Patient Rights Act 2002].
   Google Scholar
• Draulans D Genen sturen de strijd tegen kanker [Genes steer the fight against cancer]. Knack [Internet]. [ updated 2014 May 21; cited 2017 Apr 11]; [about 5 screens]. Dutch. Available from: http://homes.esat.kuleuven.be/~bioiuser/symbiosys2/index.php/9-press/176-ieder-dna-en-dus-ook-ieder-kankergezwel-is-uniek
   Google Scholar
• Vektis. The Netherlands: vektis. Zorgthermometer: verzekerden in beeld 2015 [Health insured in the picture] [Internet]; [ updated 2015 Apr; cited 2017 Apr 11]; [24 pages]. Dutch. Available from: https://www.vektis.nl/downloads/Publicaties/2015/Zorgthermometer%20nr14/
   Google Scholar
• NZA. The Netherlands: nederlandse Zorgautoriteit. Marktscan van de zorgverzekeringsmarkt 2015 [Scan of the health insurance market in 2015] [Internet]; [ updated 2015 Sep 24; cited 2017 Apr 11]; [85 pages]. Dutch. Available from: https://www.nza.nl/publicaties/1048188/Marktscan_Zorgverzekeringsmarkt_2015_update_mei_2016.
   Google Scholar
• ONVZ. The Netherlands: ONVZ Zorgverzekeraar. Voorwaardelijke toelating tot het basispakket [Conditional access to the basic package] [Internet]; [ updated 2016 Oct 1 [ cited 2017 Apr 11]; [19 pages]. Dutch. Available from: https://www.onvz.nl/ONVZ/documenten/2016/Polisvoorwaarden/onvz-voorwaardelijke-toelating-tot-het-basispakket-2016.pdf
   Google Scholar
• OECD. Paris: organisation for Economic Cooperation and Development; c2016. OECD Health statistics 2015, figures for 2013; c2016 [Internet] [ cited 2017 Jan 11]; [1 screen]. Available from: http://stats.oecd.org/index.aspx?DataSetCode=HEALTH_STAT#
   Google Scholar
• Ziekenhuis verbiedt kankerkuur [Hospital forbids cancer treatment]. De Telegraaf [Internet]. [ updated 2015 Jun 16; cited 2017 Apr 11]; Health:[about 3 screens]. Available from: http://www.telegraaf.nl/gezondheid/24164283/___Ziekenhuis_verbiedt_kankerkuur___.html
   Google Scholar
• Rijksoverheid. The Netherlands: rijksoverheid. Beantwoording Kamervragen over het aanbieden van de NIPT in België [The Dutch government responds to parliamentary questions on NIPT being offered to Dutch patients in Belgium] [Internet]; [ updated 2015 Jan 13; cited 2017 Apr 11]; [about 3 screens]. Dutch. Available from: https://www.rijksoverheid.nl/documenten/kamerstukken/2015/01/13/beantwoording-kamervragen-over-het-aanbieden-van-de-nipt-in-belgie
   Google Scholar
• Article 25 septies. §1, 4° Wet betreffende de verplichte verzekering voor geneeskundige verzorging en uitkeringen gecoördineerd op 14 juli 1994 [Health Insurance Act]. Brussels: Belgisch Staatsblad; 1994.
   Google Scholar
• Richards M. Improving access to medicines for NHS patients: a report to the secretary of state for health UK: Crown. ; 2008. Available from: http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_089952.pdf
   Google Scholar
• Oliver A, Mossialos E. Equity of access to health care: outlining the foundations for action. J Epidemiol Commun Health. 2004;58(8):1–10.
   Web of Science ®Google Scholar
• Donabedian A. Social responsibility for personal health services: an examination of basic values. Inquiry. 1971;8(2):3–19.
   Google Scholar
• Enthoven AC, van de Ven WPPM. Going Dutch –. managed-competition health insurance in the Netherlands. N Engl J Med. 2007;357(24):2421–2423.
   PubMed Web of Science ®Google Scholar
• Pauly MV. Financing health care. Q Rev Econ Bus. 1990;30(4):63–80.
   Google Scholar
• Dybczak K, Przywara B The role of technology in health care expenditure in the EU. European Commission, Economic and Financial Affairs, Economic Papers 400; 2010 Feb [ cited 2017 Apr 11]. Available from: http://ec.europa.eu/economy_finance/publications/economic_paper/2010/ecp400_en.htm
   Google Scholar
• Jost T, editor. Health care coverage determinations. Maidenhead: Open University Press; 2005.
   Google Scholar
• Smith P. Incorporating financial protection into decision rules for publicly financed health care treatments. Health Econ. 2013;22(2):180–193.
   PubMed Web of Science ®Google Scholar
• Pauly M. Cost effectiveness analysis and insurance coverage: solving a puzzle. Health Econ. 2015;24(5):506–515.
   Web of Science ®Google Scholar